ISAC is delighted to invite you to its next free webinar, organised by the ISAC MRSA Working Group.

Antibiotic susceptibility patterns used for epidemiologic surveillance of Staphylococcus aureus

11 July 2024 at 15.00 CET / 09.00 EST*

There have been recent studies in the US and Spain showing emerging resistance in MSSA to macrolides and to tetracyclines. ST398 S. aureus strains, initially identified as “livestock associated MRSA” are a fascinating example. Studies of clinical S. aureus strains have in some cases included molecular epidemiology suggesting that ST398 S. aureus strains may be responsible for a change in the relative prevalence of strains causing clinically significant disease. Other studies have examined national or transnational emergence of various increasingly common strains of MRSA and MSSA, using susceptibility patterns to track strain emergence or change over time. Join this webinar and hear from 3 experts in the field on these topics.


* Find your start time by time zone
** Certificates of attendance are available for those attending the majority of the webinar.


Dr Margaret Carrel (University of Iowa)

"Exploring the surveillance potential of phenotypic susceptibility tests in outpatient S. aureus infections among US Veterans, 2010-2019"

Dr Carrel is a health geographer in the Department of Geographical & Sustainability Sciences at the University of Iowa. Her research centres on exploring geographic patterns of health and disease using GIS and spatial statistical techniques. Dr Carrel’s work with the Iowa RESEARCH (Research & Evaluation to Solve the Emergence of Antimicrobial Resistance in Communities and Hospitals) Group focuses on spatiotemporal patterns of drug resistance in bacteria as well as the socioenvironmental contexts where drug resistance is observed.

Dr Sabrina N. Di Gregorio (University of Buenos Aires)

"A 2019 prospective survey of the genomic epidemiology of S. aureus in South America: results from the first StaphNET-SA network"

Dr Sabrina Di Gregorio is Head of Practical Assignments in Microbiology at the University of Buenos Aires (UBA) and CONICET Assistant Researcher, based at “Instituto de Bacteriología y Virología Molecular, Facultad de Farmacia y Bioquímica, UBA”.

Her research focuses on the epidemiological and molecular aspects of antimicrobial resistance and virulence in Staphylococcus aureus.

She has advanced her expertise through significant international research experiences, including training in molecular biology in 2011 at the Centre for Protein Engineering, University of Liège, Belgium, and specializing in bioinformatics during 2018 and 2019 at The Centre for Genomic Pathogen Surveillance, Wellcome Trust Sanger Institute, United Kingdom.

Dr Sanjat Kanjilal (Harvard University)

"Insights into the changing epidemiology of S. aureus in Boston, Massachusetts using routinely collected electronic health record data"

Dr Kanjilal is an Assistant Professor in the Department of Population Medicine at the Harvard Pilgrim Health Care Institute and the Associate Medical Director of Clinical Microbiology at the Brigham & Women’s Hospital (BWH). He is also an infectious diseases physician at the BWH and the course director of HST 040, Mechanisms of Microbial Pathogenesis, at Harvard Medical School.

Dr Kanjilal's research interests focus on harnessing observational and experimental data to improve the diagnosis and management of infectious diseases. Specific areas of work include the development of decision support tools built over artificial intelligence models that assist healthcare providers in a variety of tasks such as choosing optimal antibiotic treatments and diagnostic testing strategies and in granular modeling of antimicrobial resistance for infection control.


Dr Michael David (University of Pennsylvania)

Dr David, an infectious diseases physician, is the director of the MRSA [methicillin-resistant S. aureus] Research Program and also the director of the Skin and Soft Tissue Clinic at Penn. Before moving to Penn in 2017, for eight years he was on the faculty of the Department of Medicine of the University of Chicago. He works on the inpatient consultation service and in the outpatient clinic, providing care for patients with a variety of infections.

Prof. Margreet Vos (ErasmusMC)

Prof. Margreet C.Vos is a Clinical Microbiologist / Professor of Healthcare related Infections at ErasmusMC, Rotterdam (NL).

She is a well-known invited speaker at international congress, 235 peer- reviewed publications (H-index 39) on MDRO, hand-hygiene, MRSA/MSSA, outbreaks, transmission, hospital environment and -design and endoscope-related contamination. She initiated and chaired the national working group on infection prevention and the committee on the organization/quality of hospital infection prevention. She is member of the ESCMID-EUCIC Guideline on MDRO and ESGE/ESGENA Guideline duodenoscopes. She was the project-leader of JPI-MACOTRA consortium: (un)success of MRSA. She is the scientific officer of ESGNI /ESCMID) and chair of the MRSA-ISAC working-group.